Management of metastatic colorectal cancer patients: Guidelines of the Italian Medical Oncology Association (AIOM)

Lisa Salvatore, Giuseppe Aprile, Ermenegildo Arnoldi, Carlo Aschele, Carlo Carnaghi, Maurizio Cosimelli, Evaristo Maiello, Nicola Normanno, Stefania Sciallero, Francesca Valvo, Giordano D. Beretta

Research output: Contribution to journalReview article

Abstract

In the past 15 years, the outcome for patients with metastatic colorectal cancer has substantially improved owing to the availability of new cytotoxic and biological agents along with many significant advances in molecular selection, the use of personalised therapy and locoregional treatment, a more widespread sharing of specific professional experiences (multidisciplinary teams with oncologists, surgeons, radiotherapists, radiologists, biologists and pathologists), and the adoption of patient-centred healthcare strategies. The Italian Medical Oncology Association (AIOM) has developed evidence-based recommendations to help oncologists and all professionals involved in the management of patients with metastatic colorectal cancer in their daily clinical practice.

Original languageEnglish
Article numbere000147
JournalESMO Open
Volume2
Issue number1
DOIs
Publication statusPublished - Apr 1 2017

Keywords

  • AIOM
  • guidelines
  • Italian
  • Metastatic colorectal cancer
  • recommendation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Management of metastatic colorectal cancer patients: Guidelines of the Italian Medical Oncology Association (AIOM)'. Together they form a unique fingerprint.

  • Cite this